HDA 2023 Traceability Seminar: GS1 Updates on Implementation Guides

Published on: 

Pharma Commerce provides a synopsis of the presentation.

On the second and final day of this year’s Traceability Seminar, a session titled “GS1 Updates on Implementation Guides,” offered three individuals who spoke on resources for the industry to aid in Drug Supply Chain Security Act (DSCSA) readiness, expectations of trading partners, and more details. The speakers included:

  • Scott A. Mooney, VP, distribution operations, traceability, McKesson Corporation
  • Tracy Nasarenko, senior director, community engagement, GS1 US
  • Elizabeth Waldorf, director, global traceability and standards, TraceLink Inc.

Industry resources

The pharma industry community has leaned in together in order to solve how the industry as a whole can meet the requirements of the DSCSA. To offer more insight, the act requires the industry to build an electronic, interoperable system to identify and trace certain prescription drugs as they are distributed in the US.

GS1 has designed the GS1 Lightweight Messaging Standard to support requests and responses forverification of product identifiers for serialized pharmaceutical products. Designed to support verification routing services (VRS) systems for DSCSA verification, it is intended to provide a simple lightweight messaging framework for asking questions and receiving appropriate information.

Expectations of trading partners

The team stressed the importance of having readable and scannable barcodes, sharing of master data, and accurate information. Regarding Electronic Product Code Information Services (EPCIS), all parties must be onboarded with customers and rely on standardized use to support interoperability.